Literature DB >> 31440857

HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?

Livio Garattini1, Anna Padula2.   

Abstract

Entities:  

Keywords:  I1; I2; I3

Year:  2020        PMID： 31440857     DOI： 10.1007/s10198-019-01103-9

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  35 in total

1.  International comparison of the definition and the practical application of health technology assessment.

Authors:  Eva Draborg; Dorte Gyrd-Hansen; Peter Bo Poulsen; Mogens Horder
Journal:  Int J Technol Assess Health Care       Date:  2005       Impact factor: 2.188

2.  A history of health technology assessment at the European level.

Authors:  David Banta; Finn Børlum Kristensen; Egon Jonsson
Journal:  Int J Technol Assess Health Care       Date:  2009-06-18       Impact factor: 2.188

3.  HTA and its legal issues: a framework for identifying legal issues in health technology assessment.

Authors:  Daniel Widrig; Brigitte Tag
Journal:  Int J Technol Assess Health Care       Date:  2014-12       Impact factor: 2.188

4.  Assessing the relative efficacy of new drugs: an emerging opportunity.

Authors:  Hans-Georg Eichler; Andrew Thomson; Irmgard Eichler; Sebastian Schneeweiss
Journal:  Nat Rev Drug Discov       Date:  2015-07       Impact factor: 84.694

5.  Integrating ethics in health technology assessment: many ways to Rome.

Authors:  Björn Hofmann; Wija Oortwijn; Kristin Bakke Lysdahl; Pietro Refolo; Dario Sacchini; Gert Jan van der Wilt; Ansgar Gerhardus
Journal:  Int J Technol Assess Health Care       Date:  2015-06-11       Impact factor: 2.188

Review 6.  European collaboration on relative effectiveness assessments: What is needed to be successful?

Authors:  Sarah Kleijnen; Wil Toenders; Folkert de Groot; Mirjana Huic; Elisabeth George; Beate Wieseler; Mira Pavlovic; Anna Bucsics; Paolo D Siviero; Martin van der Graaff; Rafał Rdzany; Finn Børlum Kristensen; Wim Goettsch
Journal:  Health Policy       Date:  2015-02-07       Impact factor: 2.980

7.  Health technology assessment: research trends and future priorities in Europe.

Authors:  Camilla Palmhøj Nielsen; Tina Maria Funch; Finn Børlum Kristensen
Journal:  J Health Serv Res Policy       Date:  2011-07

8.  European Medicines Agency: leave the UK but remain the same.

Authors:  Livio Garattini; Alessandro Curto
Journal:  J R Soc Med       Date:  2016-09       Impact factor: 5.344

9.  INTEGRATE-HTA: THE PERSPECTIVE OF EUnetHTA.

Authors:  Kristian Lampe; Petra Schnell-Inderst
Journal:  Int J Technol Assess Health Care       Date:  2017-09-06       Impact factor: 2.188

10.  Most important barriers and facilitators of HTA usage in decision-making in Europe.

Authors:  K L Cheung; S M A A Evers; H De Vries; P Levy; S Pokhrel; T Jones; M Danner; J Wentlandt; L Knufinke; S Mayer; M Hiligsmann
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2018-01-05       Impact factor: 2.217
View more
  2 in total

1.  Comment on: 'NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence'.

Authors:  Livio Garattini; Nicholas Freemantle
Journal:  Pharmacoeconomics       Date:  2020-01       Impact factor: 4.981

Review 2.  The Impact of Micro and Macro Level Factors on the Working and Living Conditions of Migrant Care Workers in Italy and Israel-A Scoping Review.

Authors:  Oliver Fisher
Journal:  Int J Environ Res Public Health       Date:  2021-01-07       Impact factor: 3.390
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.